Bill > SB0275

This bill amends Utah's laws regarding stem cell therapy by establishing comprehensive disclosure and consent requirements for healthcare providers performing stem cell treatments that have not been approved by the FDA. Specifically, the bill requires healthcare providers to provide patients with a prominent written notice explaining that the stem cell therapy is not FDA-approved, displayed in a large font and posted visibly in the office. Before performing the therapy, providers must obtain a signed consent form from the patient (or their legal representative) that details the treatment's nature, potential results, alternative treatments, and possible risks and benefits. The bill also mandates that any advertisements for such stem cell therapies include the same disclosure notice, either in print or verbally. The law defines stem cell therapy as treatments using placental perinatal stem cells, explicitly excluding treatments derived from fetal or embryonic tissues. Additionally, the bill allows healthcare providers to supply or receive human cells and tissues for stem cell therapy, provided they confirm they will give patients the required notice. The bill provides exceptions for providers with FDA investigational drug approvals or those working under certified institutions. Any violation of these requirements is considered unprofessional conduct, and the bill will take effect on May 7, 2025.

Health and Social Services

https://le.utah.gov/~2025/bills/static/SB0275.html